Roshal R. Patel

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials

Willemijn S.M.E. Theelen, Dawei Chen, Vivek Verma et al. · The Lancet Respiratory Medicine · 2020 · 540 citations

Medicine, Randomised Trials, Immune Checkpoint Inhibitor +6

Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials

Dawei Chen, Vivek Verma, Roshal R. Patel et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 127 citations

Phase 1/2, Lymphoid Neoplasia, Cancer Immunosurveillance +8

Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy

Dawei Chen, Roshal R. Patel, Vivek Verma et al. · Radiotherapy and Oncology · 2020 · 99 citations

Adaptive Radiotherapy, Survival Outcomes, Oncology +8

Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC

James W. Welsh, John V. Heymach, Chunxiao Guo et al. · Journal of Thoracic Oncology · 2020 · 93 citations · Full text

Phase 1/2, Oncology, Health Sciences +8

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial

Roshal R. Patel, Kewen He, Hampartsoum B. Barsoumian et al. · Radiotherapy and Oncology · 2021 · 89 citations · Full text

Radiation Medicine, Phase Ii Trial, Radiation Therapy +8